NCT04026087View on ClinicalTrials.gov

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

May 6, 2022

Study Completion Date

February 15, 2023

Conditions
Antibody-mediated Rejection
Trial Locations (1)

34090

CHU Lapeyronie, Montpellier

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Montpellier

OTHER

NCT04026087 - Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation | Biotech Hunter | Biotech Hunter